{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:08:50Z","timestamp":1784891330994,"version":"3.55.0"},"reference-count":101,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Clinical Psychiatry"],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1080\/10401230591002002","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T15:25:24Z","timestamp":1127229924000},"page":"113-135","source":"Crossref","is-referenced-by-count":259,"title":["History of the Discovery and Clinical Introduction of Chlorpromazine"],"prefix":"10.1177","volume":"17","author":[{"given":"Francisco","family":"L\u00f3pez-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilio","family":"Alamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Clervoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"E00001","first-page":"207","author":"L\u00f3pez-Mu\u00f1ozF","year":"1998","unstructured":"L\u00f3pez-Mu\u00f1oz, F and Alamo, C and Cuenca, E.(1998) Farmacos antipsic\u00f3ticos. In Historia de la Neuropsicofarmacolog\u00eda. Una nueva aportaci\u00f3n a la terap\u00e9utica farmacol\u00f3gica de los trastornos del Sistema Nervioso Central<\/i>. ( pp. 207 - 243 ). Madrid : Ediciones Eurobook, S.L. and Servicio de Publicaciones de la Universidad de Alcal\u00e1."},{"key":"E00002","first-page":"206","volume":"60","author":"Laborit H","year":"1952","unstructured":"Laborit, H and Huguenard, P and Alluaume, R. (1952) Un nouveau stabilisateur v\u00e9g\u00e9tatif (le 4560 RP) Presse M\u00e9d<\/i>, 60, pp. 206 - 208.","journal-title":"Presse M\u00e9d"},{"key":"E00003","first-page":"16","volume":"66","author":"L\u00f3pez-Mu\u00f1oz F","year":"2003","unstructured":"L\u00f3pez-Mu\u00f1oz, F and Alamo, C and Cuenca, E. (2003) Aportaci\u00f3n de la clorpromazina al desarrollo de la psiquiatr\u00eda Arch Psiquiatria<\/i>, 66, pp. 16 - 34.","journal-title":"Arch Psiquiatria"},{"key":"E00004","first-page":"112","volume":"110","author":"Delay J","year":"1952","unstructured":"Delay, J and Deniker, P and Harl, JM. (1952) Utilisation en th\u00e9rapeutique d'une ph\u00e9nothiazine d'action centrale selective (4560 RP) Ann M\u00e9d Psychol<\/i>, 110, pp. 112 - 117.","journal-title":"Ann M\u00e9d Psychol"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02178342","volume":"9","author":"Bein HJ","year":"1954","unstructured":"Bein, HJ. (1954) Zur Pharmakologie des reserpin, eines neuen alkaloids aus rauwalfia serpentina bent Experientia<\/i>, 9, pp. 107 - 110.","journal-title":"Experientia"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.1954.tb45922.x","volume":"59","author":"Kline NS","year":"1954","unstructured":"Kline, NS. (1954) Use of rauwolfia serpentina bebth in neuropsychiatric conditions Ann New York Acad Sci<\/i>, 59, pp. 107 - 132.","journal-title":"Ann New York Acad Sci"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/ajp.117.2.147","volume":"117","author":"Prince R","year":"1960","unstructured":"Prince, R. (1960) The use of Rauwolfia for the treatment of Psychosis by Nigerian native doctors Am J Psychiatry<\/i>, 117, pp. 147 - 149. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Am J Psychiatry"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","volume":"2","author":"Cade JFJ","year":"1949","unstructured":"Cade, JFJ. (1949) Lithium salts in the treatment of psychotic excitement Med J Austral<\/i>, 2, pp. 349 - 352.","journal-title":"Med J Austral"},{"key":"E00009","first-page":"9","author":"CaldwellAE","year":"1970","unstructured":"Caldwell, AE.(1970) History of psychopharmacology. In Principles of Psychopharmacology<\/i>. ( pp. 9 - 30 ). New York : Academic Press."},{"key":"E00010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00310617","volume":"89","author":"Jacobsen E","year":"1986","unstructured":"Jacobsen, E. (1986) The early history of psychotherapeutic drugs Psychopharmacology<\/i>, 89, pp. 138 - 144. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CROSSREF]<\/a>","journal-title":"Psychopharmacology"},{"key":"E00011","first-page":"253","volume":"14","author":"Deniker P","year":"1989","unstructured":"Deniker, P. (1989) From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics) Psychiatr J Univ Ottawa<\/i>, 14, pp. 253 - 259.","journal-title":"Psychiatr J Univ Ottawa"},{"key":"E00012","first-page":"263","volume":"14","author":"Lehmann HE","year":"1989","unstructured":"Lehmann, HE. (1989) The introduction of chlorpromazine in North America Psychiatr J Univ Ottawa<\/i>, 14, pp. 263 - 265.","journal-title":"Psychiatr J Univ Ottawa"},{"key":"E00013","first-page":"71","volume":"5","author":"Ayd FJ","year":"1991","unstructured":"Ayd, FJ. (1991) The early history of modern psychopharmacology Neuropsychopharmacology<\/i>, 5, pp. 71 - 84. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Neuropsychopharmacology"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0193-953X(18)30098-4","volume":"17","author":"Frankenburg FR","year":"1994","unstructured":"Frankenburg, FR. (1994) History of the development of antipsychotic medication Psychiatr Clin North Am<\/i>, 17, pp. 531 - 540. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Psychiatr Clin North Am"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0957154X9400501705","volume":"5","author":"Shepherd M","year":"1994","unstructured":"Shepherd, M. (1994) Neurolepsis and the psychopharmacological revolution: Myth and reality Hist Psychiatry<\/i>, 5, pp. 89 - 96. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Hist Psychiatry"},{"key":"E00016","author":"HealyD","year":"1996","unstructured":"Healy, D.(1996) The Psychopharmacologists<\/i>. New York : Chapman and Hall."},{"key":"E00017","author":"HealyD","year":"1999","unstructured":"Healy, D.(1999) The Psychopharmacologists II<\/i>. London : Arnold."},{"key":"E00018","author":"HealyD","year":"2000","unstructured":"Healy, D.(2000) The Psychopharmacologists III<\/i>. London : Arnold."},{"key":"E00019","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/070674379704200205","volume":"42","author":"Lehmann HE","year":"1997","unstructured":"Lehmann, HE and Ban, TA. (1997) The history of the psychopharmacology of schizophrenia Can J Psychiatry<\/i>, 42, pp. 152 - 163. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Can J Psychiatry"},{"key":"E00020","unstructured":"L\u00f3pez-Mu\u00f1oz F, Alamo C, Cuenca E: La \u201cD\u00e9cada de Oro\u201d de la Psicofarmacolog\u00eda (1950\u20131960): Trascendencia hist\u00f3rica de la introducci\u00f3n cl\u00ednica de los psicof\u00e1rmacos cl\u00e1sicos, Psiquiatria.COM (electronic journal), Sep (cited 7 Jan 2001), 4 (3) L\u00f3pez-Mu\u00f1oz F, Alamo C, Cuenca E: La \u201cD\u00e9cada de Oro\u201d de la Psicofarmacolog\u00eda (1950\u20131960): Trascendencia hist\u00f3rica de la introducci\u00f3n cl\u00ednica de los psicof\u00e1rmacos cl\u00e1sicos, Psiquiatria.COM (electronic journal), Sep (cited 7 Jan 2001), 4 (3)"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-440X(99)90082-2","volume":"40","author":"Shen WW","year":"1999","unstructured":"Shen, WW. (1999) A history of antipsychotic drug development Compr Psychiatry<\/i>, 40, pp. 407 - 414. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CROSSREF]<\/a>","journal-title":"Compr Psychiatry"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1176\/appi.ps.51.3.333","volume":"51","author":"Cancro R","year":"2000","unstructured":"Cancro, R. (2000) The introduction of neuroleptics: A psychiatric revolution Psychiatr Serv<\/i>, 51, pp. 333 - 335. [PUBMED]<\/a>[INFOTRIEVE]<\/a>[CROSSREF]<\/a>","journal-title":"Psychiatr Serv"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0278-5846(01)00160-9","volume":"25","author":"Ban TA","year":"2001","unstructured":"Ban, TA. (2001) Pharmacotherapy of mental illness. A historical analysis Prog Neuro-Psychopharmacol Biol Psychiatry<\/i>, 25, pp. 709 - 727. [CROSSREF]<\/a>","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM195603152541105","volume":"254","author":"Altschule MD","year":"1956","unstructured":"Altschule, MD. (1956) Use of chlorpromazine and reserpine in mental disorders New Eng J Med<\/i>, 254, pp. 515 - 519. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"New Eng J Med"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0278-5846(03)00165-9","volume":"28","author":"L\u00f3pez-Mu\u00f1oz F","year":"2004","unstructured":"L\u00f3pez-Mu\u00f1oz, F and Alamo, C and Rubio, G and Cuenca, E. (2004) Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology Prog Neuro-Psychopharmacol Biol Psychiatry<\/i>, 28, pp. 205 - 208. [CROSSREF]<\/a>","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"E00026","unstructured":"Alamo C, L\u00f3pez-Mu\u00f1oz F, Cuenca E: El desarrollo de la clozapina y su papel en la conceptualizaci\u00f3n de la atipicidad antipsic\u00f3tica, Psiquiatria.COM (electronic journal), Sep (cited 7 Jan 2001), 4 (3) Alamo C, L\u00f3pez-Mu\u00f1oz F, Cuenca E: El desarrollo de la clozapina y su papel en la conceptualizaci\u00f3n de la atipicidad antipsic\u00f3tica, Psiquiatria.COM (electronic journal), Sep (cited 7 Jan 2001), 4 (3)"},{"key":"E00027","author":"ShorterE","year":"1997","unstructured":"Shorter, E.(1997) A History of Psychiatry. In From the Era of Asylum to the Age of Prozac<\/i>. . New York : John Wiley & Sons, Inc.."},{"key":"E00028","first-page":"78","author":"LickeyME","year":"1986","unstructured":"Lickey, ME and Gordon, B.(1986) Medicamentos para las enfermedades mentales<\/i>. Barcelona : Labor."},{"key":"E00029","author":"SwazeyJP","year":"1974","unstructured":"Swazey, JP.(1974) Chlorpromazine in Psychiatry. In A Study of Therapeutic Innovation<\/i>. . Cambridge : MIT Press."},{"key":"E00030","first-page":"55","author":"ZircleCL","year":"1973","unstructured":"Zircle, CL.(1973) To tranquilizers and antidepressants: From antimalarials and antihistamines. In How Modern Medicines are Discovered<\/i>. ( pp. 55 - 77 ). Mt. Kisco : Futura."},{"key":"E00031","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/ja01235a042","volume":"66","author":"Gilman H","year":"1944","unstructured":"Gilman, H and van Ess, PR and Shirley, DA. (1944) The metalation of 10-phenylphenothiazine and of 10-ethyl-phenothiazine J Am Chem Soc<\/i>, 66, pp. 1214 - 1216. [CROSSREF]<\/a>","journal-title":"J Am Chem Soc"},{"key":"E00032","first-page":"432","volume":"101","author":"Daumezon G","year":"1943","unstructured":"Daumezon, G and Cassan, L. (1943) essai de th\u00e9rapeutique abortive d'acc\u00e8s maniaco-d\u00e9pressifs par le 2339 RP Ann Med Psychol<\/i>, 101, pp. 432 - 435.","journal-title":"Ann Med Psychol"},{"key":"E00033","author":"LaboritH","year":"1952","unstructured":"Laborit, H.(1952) R\u00e9action organique \u00e0 l'agression et choc.<\/i>. Paris : Masson & Cie."},{"key":"E00034","first-page":"21","volume":"1\u20132","author":"Thuillier J","year":"1994","unstructured":"Thuillier, J. (1994) Naissance de la psychopharmacologie ou \u201cune histoire de nez\u201d Urgences<\/i>, 1\u20132, pp. 21 - 22.","journal-title":"Urgences"},{"key":"E00035","first-page":"107","author":"ThuillierJ","year":"1981","unstructured":"Thuillier, J.(1981) El nuevo rostro de la locura<\/i>. Barcelona : Planeta."},{"key":"E00036","first-page":"305","volume":"92","author":"Courvoisier S","year":"1953","unstructured":"Courvoisier, S and Fournel, J and Ducrot, R and (1953) Propi\u00e9t\u00e9s pharmacodynamiques du chlorhydrate de chloro-3 (dimethypamine 3'propyl)-10 ph\u00e9notiazine (4560RP) Arch Int Pharmacodyn Ther<\/i>, 92, pp. 305 - 361. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"E00037","first-page":"25","volume":"17","author":"Courvoisier S","year":"1956","unstructured":"Courvoisier, S. (1956) Pharmacodynamic basis for the use of chlorpromazine in psychiatry J Clin Exp Psychopathol<\/i>, 17, pp. 25 - 37. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Clin Exp Psychopathol"},{"key":"E00038","first-page":"1329","volume":"59","author":"Laborit H","year":"1951","unstructured":"Laborit, H and Huguenard, P. (1951) L'hibernation artificielle par moyens pharmacodynamiques of physiques Presse M\u00e9d<\/i>, 59, pp. 1329.","journal-title":"Presse M\u00e9d"},{"key":"E00039","first-page":"971","volume":"140","author":"Chertock L","year":"1982","unstructured":"Chertock, L. (1982) 30 ans apr\u00e8s: la petite histoire de la d\u00e9couverte des neuroleptiques Ann M\u00e9d Psychol<\/i>, 140, pp. 971 - 974.","journal-title":"Ann M\u00e9d Psychol"},{"key":"E00040","first-page":"232","volume":"9","author":"Laborit H","year":"1952","unstructured":"Laborit, H and Jaulmes, C and B\u00e9nitte, A. (1952) Certain experimental aspects of artificial hibernation Anest Analg<\/i>, 9, pp. 232.","journal-title":"Anest Analg"},{"key":"E00041","first-page":"332","volume":"110","author":"Hamon J","year":"1952","unstructured":"Hamon, J and Paraire, J and Velluz, J. (1952) Remarques sur l'action du 4560RP sur l'agitation maniaque Ann M\u00e9d Psychol<\/i>, 110, pp. 332 - 335.","journal-title":"Ann M\u00e9d Psychol"},{"key":"E00042","first-page":"423","volume":"43","author":"Shen WW","year":"1998","unstructured":"Shen, WW and Giesler, MC. (1998) The discoverers of the therapeutic effect of chlorpromazine in psychiatry: Qui \u00e9taient les vrais premiers practiciens? Can J Psychiatry<\/i>, 43, pp. 423 - 424. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Can J Psychiatry"},{"key":"E00043","first-page":"149","volume":"XVII","author":"Ginestet D","year":"1991","unstructured":"Ginestet, D. (1991) Les neuroleptiques. D\u00e9veloppement et situation actuelle L'Enc\u00e9phale<\/i>, XVII, pp. 149 - 152.","journal-title":"L'Enc\u00e9phale"},{"key":"E00044","first-page":"168","volume":"27","author":"King C","year":"2002","unstructured":"King, C and Voruganti LN, P. (2002) What's in a name? The evolution of the nomenclature of antipsychotic drugs Rev Psychiatry Neurosci<\/i>, 27, pp. 168 - 175.","journal-title":"Rev Psychiatry Neurosci"},{"key":"E00045","first-page":"267","volume":"110","author":"Delay J","year":"1952","unstructured":"Delay, J and Deniker, P and Harl, JM. (1952) Traitement des \u00e9tats d'excitation et d'agitation par une m\u00e9thode m\u00e9dicamenteuse d\u00e9riv\u00e9e de l'hibernoth\u00e9rapie Ann M\u00e9d Psychol<\/i>, 110, pp. 267 - 273.","journal-title":"Ann M\u00e9d Psychol"},{"key":"E00046","first-page":"398","volume":"110","author":"Delay J","year":"1952","unstructured":"Delay, J and Deniker, P and Harl, JM and Grasset, A. (1952) Traitements des \u00e9tats confusionnels par le chlorte de dem\u00e9thylaminoprppyl-N-chloro-ph\u00e9nothiazine (4560 RP) Ann M\u00e9d Psychol<\/i>, 110, pp. 398 - 403.","journal-title":"Ann M\u00e9d Psychol"},{"key":"E00047","first-page":"1","author":"PichotP","year":"1996","unstructured":"Pichot, P.(1996) The discovery of chlorpromazine and the place of psychopharmacology in the history of the psychiatry. In The Psychopharmacologists<\/i>. ( pp. 1 - 27 ). New York : Chapman and Hall."},{"key":"E00048","first-page":"150","volume":"54","author":"Sigwald J","year":"1953","unstructured":"Sigwald, J and Bouttier, D. (1953) Le chlorhydrate de chloro-3(dim\u00e9thylamino-3-propyl)-10-ph\u00e9no-thiazine en pratique neuro-psychiatrique courante Ann Med<\/i>, 54, pp. 150 - 184.","journal-title":"Ann Med"},{"key":"E00049","first-page":"944","volume":"60","author":"Deschamps A","year":"1952","unstructured":"Deschamps, A. (1952) Hibernation artificielle en psychiatrie Presse M\u00e9d<\/i>, 60, pp. 944 - 946.","journal-title":"Presse M\u00e9d"},{"key":"E00050","first-page":"1","author":"Lemp\u00e9ri\u00e8reT","year":"1999","unstructured":"Lemp\u00e9ri\u00e8re, T.(1999) In the beginning in Paris. In The Psychopharmacologists II<\/i>. ( pp. 1 - 15 ). London : Arnold."},{"key":"E00051","author":"HealyD","year":"1997","unstructured":"Healy, D.(1997) The Antidepressant Era<\/i>. Cambridge : Harvard University Press."},{"key":"E00052","first-page":"237","author":"LambertPA","year":"1998","unstructured":"Lambert, PA.(1998) Chlorpromazine: A true story of the progress effected by this drug. In The Rise of Psychopharmacology and the Story of CINP<\/i>. ( pp. 237 - 243 ). Budapest : Animula Publishing House."},{"key":"E00053","first-page":"371","author":"BattegayR","year":"2001","unstructured":"Battegay, R.(2001) Forty-four years of psychiatry and psychopharmacology. In The Psychopharmacologists III<\/i>. ( pp. 371 - 394 ). London : Arnold."},{"key":"E00054","first-page":"206","volume":"60","author":"Labhardt F","year":"1953","unstructured":"Labhardt, F. (1953) Die largactiltherapie bei schizophrenien und anderen psychotischen st\u00f6rungen Schw Med Wochensch<\/i>, 60, pp. 206 - 208.","journal-title":"Schw Med Wochensch"},{"key":"E00055","first-page":"355","volume":"79","author":"Labhardt F","year":"1957","unstructured":"Labhardt, F. (1957) Die ergebnisse der Largactil-behandlung schizophrener von 1953 bis 1955 an der Basler Psychiatrischen Universit\u00e4tsklinik Schw Arch NeurolPsychiatr<\/i>, 79, pp. 355 - 389.","journal-title":"Schw Arch NeurolPsychiatr"},{"key":"E00056","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bmj.2.4887.560","volume":"2","author":"Elkes J","year":"1954","unstructured":"Elkes, J and Elkes, C. (1954) Effects of chlorpromazine on the behaviour of chronically overactive psychotic patients Br Med J<\/i>, 2, pp. 560 - 565.","journal-title":"Br Med J"},{"key":"E00057","first-page":"5","volume":"26","author":"Griffin DM","year":"1994","unstructured":"Griffin, DM. (1994) An historic oversight Can Psychiatr Assoc Bull<\/i>, 26, pp. 5.","journal-title":"Can Psychiatr Assoc Bull"},{"key":"E00058","first-page":"32","author":"Sarwer-FornerGJ","year":"1998","unstructured":"Sarwer-Forner, GJ.(1998) Personal reminiscences of the early days of psychopharmacology. In The Rise of Psychopharmacology and the Story of CINP<\/i>. ( pp. 32 - 35 ). Budapest : Animula Publishing House."},{"key":"E00059","first-page":"116","volume":"71","author":"Azima H","year":"1954","unstructured":"Azima, H and Ogle, W. (1954) Effects of Largactil in mental syndrome Can Med Assoc J<\/i>, 71, pp. 116 - 121. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Can Med Assoc J"},{"key":"E00060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archneurpsyc.1954.02320380093011","volume":"71","author":"Lehmann HE","year":"1954","unstructured":"Lehmann, HE and Hanrahan, GE. (1954) Chlorpromazine, new inhibiting agent for psychomotor excitement and manic states Arch Neurol Psychiatry<\/i>, 71, pp. 227 - 237.","journal-title":"Arch Neurol Psychiatry"},{"key":"E00061","first-page":"259","author":"LehmannHE","year":"1985","unstructured":"Lehmann, HE.(1985) A clinical psychopharmacologist remember and takes stock. In Psychopharmacology: Impact on Clinical Psychiatry<\/i>. ( pp. 259 - 266 ). St. Louis : Ishiyaku EuroAmerica, Inc. Publishers."},{"key":"E00062","first-page":"17","author":"CookL","year":"1999","unstructured":"Cook, L.(1999) Pharmacology, behaviour and chlorpromazine. In The Psychopharmacologists II<\/i>. ( pp. 17 - 38 ). London : Arnold."},{"key":"E00063","first-page":"1","author":"PichotP","year":"1994","unstructured":"Pichot, P.(1994) \u00bfA d\u00f3nde se dirige la psicofarmacolog\u00eda?. In Avances en Psicofarmacolog\u00eda<\/i>. ( pp. 1 - 15 ). Barcelona : J.R. Prous S.A.."},{"key":"E00064","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/jama.1954.03690190024007","volume":"155","author":"Winkelman NW","year":"1954","unstructured":"Winkelman, NW. (1954) Chlorpromazine in the treatment of neuropsychiatric disorders J Am Med Assoc<\/i>, 155, pp. 18 - 21. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Am Med Assoc"},{"key":"E00065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM195410212511703","volume":"251","author":"Bower WH","year":"1954","unstructured":"Bower, WH. (1954) Chlorpromazine in psychiatric illness New Eng J Med<\/i>, 251, pp. 689 - 692. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"New Eng J Med"},{"key":"E00066","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/jama.1955.02960190005002","volume":"159","author":"Cohen IM","year":"1955","unstructured":"Cohen, IM and Archer, JD. (1955) Liver function and hepatic complications in patients receiving chlorpromazine J Am Med Assoc<\/i>, 159, pp. 99 - 101. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Am Med Assoc"},{"key":"E00067","first-page":"19","volume":"13","author":"Delay J","year":"1956","unstructured":"Delay, J and Deniker, P. (1956) Chlorpromazine and neuroleptic treatments in psychiatry J Clin Exp Psychophatol Quart Rev Psychiatry Neurol<\/i>, 13, pp. 19 - 24.","journal-title":"J Clin Exp Psychophatol Quart Rev Psychiatry Neurol"},{"key":"E00068","first-page":"107","volume":"17","author":"L\u00f3pez Ibor JJ","year":"1958","unstructured":"L\u00f3pez Ibor, JJ. (1958) Estudios sobre la esquizofrenia Actas Luso-Esp Neurol Psiquiatria<\/i>, 17, pp. 107 - 125.","journal-title":"Actas Luso-Esp Neurol Psiquiatria"},{"key":"E00069","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.25487","volume":"200","author":"Berger PA","year":"1978","unstructured":"Berger, PA. (1978) Medical treatment of mental illness Science<\/i>, 200, pp. 974 - 981. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Science"},{"key":"E00070","author":"DavisJM","year":"1982","unstructured":"Davis, JM and Cole, JO.(1982) F\u00e1rmacos antipsic\u00f3ticos. In Tratado de Psiquiatr\u00eda<\/i>. . Barcelona : Editorial Salvat."},{"key":"E00071","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ps.51.1.41","volume":"51","author":"Geller JL","year":"2000","unstructured":"Geller, JL. (2000) The last half-century of psychiatric services as reflected in Psychiatric Services Psychiatr Serv<\/i>, 51, pp. 41 - 67. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Psychiatr Serv"},{"key":"E00072","first-page":"151","author":"JarvikME","year":"1970","unstructured":"Jarvik, ME.(1970) Drug used in the treatment of psychiatric disorders. In The Pharmacological Basis of Therapeutics4th<\/i>. ( pp. 151 - 203 ). New York : Macmillan."},{"key":"E00073","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.1960.03590080086012","volume":"2","author":"Casey JF","year":"1960","unstructured":"Casey, JF and Bennett, IF and Lindley, CJ and (1960) Drug therapy in schizophrenia: a controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital and placebo Arch Gen Psychiatry<\/i>, 2, pp. 210 - 220. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Arch Gen Psychiatry"},{"key":"E00074","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/ajp.117.2.97","volume":"117","author":"Casey JF","year":"1960","unstructured":"Casey, JF and Lasky, JJ and Klett, CJ and Hollister, LE. (1960) Treatment of schizophrenia reactions with phenothiazine derivates Am J Psychiatry<\/i>, 117, pp. 97 - 105. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Am J Psychiatry"},{"key":"E00075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","volume":"10","author":"Cole JO","year":"1964","unstructured":"Cole, JO and NIMH Psychopharmacology Service Center Collaborative Study Group. (1964) Phenothiazine treatment in acute schizophrenia Arch Gen Psychiatry<\/i>, 10, pp. 246 - 261.","journal-title":"Arch Gen Psychiatry"},{"key":"E00076","first-page":"215","author":"HollisterLE","year":"1999","unstructured":"Hollister, LE.(1999) From hypertension to psychopharmacology. a serendipitous career. In The Psychopharmacologists II<\/i>. ( pp. 215 - 236 ). London : Arnold."},{"key":"E00077","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archpsyc.1981.01780320056006","volume":"38","author":"May PRA","year":"1981","unstructured":"May, PRA and Tuma, AH and Dixon, WJ. (1981) Schizophrenia: A follow up study of the results of 5 forms of treatment Arch Gen Psychiatry<\/i>, 38, pp. 776 - 784. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Arch Gen Psychiatry"},{"key":"E00078","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1192\/S0007125000131691","volume":"162","author":"McKenna PJ","year":"1993","unstructured":"McKenna, PJ and Bailey, PE. (1993) The strange story of clozapine Br J Psychiatry<\/i>, 162, pp. 32 - 37.","journal-title":"Br J Psychiatry"},{"key":"E00079","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","volume":"52","author":"Gilbert PL","year":"1995","unstructured":"Gilbert, PL and Harris, MJ and McAdams, LA and Jeste, DV. (1995) Neuroleptic withdrawal in schizophrenic patients. A review of the literature Arch Gen Psychiatry<\/i>, 52, pp. 173 - 188. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Arch Gen Psychiatry"},{"key":"E00080","first-page":"445","volume":"91","author":"Terzian H","year":"1954","unstructured":"Terzian, H. (1954) Etude de l'action du Largactil (4560 R.P.) et du Pendiomide sur l'activit\u00e9 \u00e9lectrique c\u00e9r\u00e9brale du lapin Rev Neurol<\/i>, 91, pp. 445 - 453. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Rev Neurol"},{"key":"E00081","first-page":"838","volume":"14","author":"Terzian H","year":"1954","unstructured":"Terzian, H. (1954) Etude \u00e9lectro-enc\u00e9phalographique de l'action centrale de la chlorpromazine Sem H\u00f4pitaux Paris<\/i>, 14, pp. 838 - 841.","journal-title":"Sem H\u00f4pitaux Paris"},{"key":"E00082","first-page":"2346","volume":"30","author":"Hiebel G","year":"1954","unstructured":"Hiebel, G and Bonvallet, M and Dell, P. (1954) Action de la chlorpromazine (Largactil, 4560 RP) au niveau du syst\u00e8me nerveux central Sem H\u00f4pitaux Paris<\/i>, 30, pp. 2346 - 2353.","journal-title":"Sem H\u00f4pitaux Paris"},{"key":"E00083","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0013-4694(54)90087-5","volume":"6","author":"Dell P","year":"1954","unstructured":"Dell, P and Bonvallet, M and Hugelin, A. (1954) Tonus sympathique, adr\u00e9naline et contr\u00f4le r\u00e9ticulaire de la motricit\u00e9 spinale EEG Clin Neurophysiol<\/i>, 6, pp. 599 - 618. [CROSSREF]<\/a>","journal-title":"EEG Clin Neurophysiol"},{"key":"E00084","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.100.418.29","volume":"100","author":"Hoffer A","year":"1954","unstructured":"Hoffer, A and Osmond, H and Smythies, J. (1954) Schizophrenia, a new approach J Ment Sci<\/i>, 100, pp. 29 - 54. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Ment Sci"},{"key":"E00085","first-page":"587","volume":"119","author":"Woolley DW","year":"1954","unstructured":"Woolley, DW and Shaw, F. (1954) A biochemical and pharmacological suggestion about certain mental disorders Science<\/i>, 119, pp. 587 - 588.","journal-title":"Science"},{"key":"E00086","first-page":"129","author":"GottliebJS","year":"1992","unstructured":"Gottlieb, JS and Frohnam, CE.(1992) The biomedical identification of schizophrenia. In Research approaches to psychiatric problems: A symposium<\/i>. ( pp. 129 - 139 ). Nueva York : Grune and Stratton."},{"key":"E00087","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","volume":"20","author":"Carlsson A","year":"1963","unstructured":"Carlsson, A and Lindqvist, M. (1963) Effect of chlorpromazine and haloperidol on the formation of 3-methoxytrytamine and normetanephrine in mouse brain Acta Pharmacol Toxicol<\/i>, 20, pp. 140 - 144.","journal-title":"Acta Pharmacol Toxicol"},{"key":"E00088","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.184.4143.1243","volume":"184","author":"Snyder SH","year":"1974","unstructured":"Snyder, SH and Banerjee, SP and Yamamura, HL and Greenberg, D. (1974) Drugs, neurotransmitters and schizophrenia Science<\/i>, 184, pp. 1243 - 1253.","journal-title":"Science"},{"key":"E00089","first-page":"3","volume":"48","author":"Rifkin A","year":"1987","unstructured":"Rifkin, A. (1987) Extrapyramidal side effects: a historical perspective J Clin Psychiatry<\/i>, 48(9), pp. 3 - 6. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Clin Psychiatry"},{"key":"E00090","first-page":"38","volume":"319","author":"Amat E","year":"1971","unstructured":"Amat, E and Cuenca, E. (1971) Neuroleptics and monoamine oxidase inhibitors Int Congr Series<\/i>, 319, pp. 38 - 48.","journal-title":"Int Congr Series"},{"key":"E00091","first-page":"309","volume":"73","author":"Labhardt F","year":"1954","unstructured":"Labhardt, F. (1954) Die Largactiltherapie bei Schizophrenien und anderen psychotischen Zust\u00e4nden Schw Arch Neurol Psychiatr<\/i>, 73, pp. 309.","journal-title":"Schw Arch Neurol Psychiatr"},{"key":"E00092","first-page":"737","volume":"112","author":"Steck H","year":"1954","unstructured":"Steck, H. (1954) Le syndrome extra-pyramidal et dienc\u00e9phalique au cours des traitements au Largactil et au Serpasil Ann M\u00e9d Psychol<\/i>, 112, pp. 737 - 743.","journal-title":"Ann M\u00e9d Psychol"},{"key":"E00093","first-page":"485","author":"DelayJ","year":"1957","unstructured":"Delay, J and Deniker, P.(1957) Caract\u00e9ristiques psycho-physiologiques des m\u00e9dicaments neuroleptiques. In Psychotropic Drugs<\/i>. ( pp. 485 - 501 ). Amsterdam : Elsevier."},{"key":"E00094","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.1961.03040120016004","volume":"175","author":"Ayd FJ","year":"1961","unstructured":"Ayd, FJ. (1961) A survey of drug-induced extrapyramidal reactions J Am Med Assoc<\/i>, 175, pp. 1054 - 1060.","journal-title":"J Am Med Assoc"},{"key":"E00095","first-page":"751","volume":"100","author":"Sigwald J","year":"1959","unstructured":"Sigwald, J and Bouttier, D and Raymond, C and Pichot, P. (1959) Quartre cas de dyskin\u00e9sie, facio-bucco-linguo-masticatrice \u00e0 l\u2019\u00e9volution prolong\u00e9e secondaire \u00e0 un traitement par les neuroleptiques Rev Neurol (Paris)<\/i>, 100, pp. 751 - 755.","journal-title":"Rev Neurol (Paris)"},{"key":"E00096","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM195606142542403","volume":"254","author":"Brooks GW","year":"1956","unstructured":"Brooks, GW. (1956) Experience with use of chlorpromazine and reserpine in psychiatry New Eng J Med<\/i>, 254, pp. 1119 - 1123. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"New Eng J Med"},{"key":"E00097","first-page":"474","volume":"18","author":"Kruse W","year":"1957","unstructured":"Kruse, W. (1957) Parkinsonism, schizophrenia, and ataractic drugs Dis Nerv System<\/i>, 18, pp. 474 - 477.","journal-title":"Dis Nerv System"},{"key":"E00098","first-page":"425","volume":"20","author":"Haase HJ","year":"1961","unstructured":"Haase, HJ. (1961) \u201cExtrapyramidal modifications of fine movements. A \u201ccondio sine qua non\u201d of fundamental therapeutic action of neuroleptic drugs Rev Can Biol<\/i>, 20, pp. 425 - 449. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Rev Can Biol"},{"key":"E00099","first-page":"579","volume":"20","author":"Freyham FA","year":"1961","unstructured":"Freyham, FA. (1961) Relationship of drug-induced neurological phenomena on therapeutic outcome Rev Can Biol<\/i>, 20, pp. 579 - 582.","journal-title":"Rev Can Biol"},{"key":"E00100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archpsyc.1965.01730020057007","volume":"13","author":"Bishop MP","year":"1965","unstructured":"Bishop, MP and Gallant, DM and Sykes, TF. (1965) Extrapyramidal side effects and therapeutic response Arch Gen Psychiatry<\/i>, 13, pp. 155 - 162. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"Arch Gen Psychiatry"},{"key":"E00101","first-page":"79","volume":"41","author":"Caroff SN","year":"1980","unstructured":"Caroff, SN. (1980) The neuroleptic malignant syndrome J Clin Psychiatry<\/i>, 41, pp. 79 - 83. [PUBMED]<\/a>[INFOTRIEVE]<\/a>","journal-title":"J Clin Psychiatry"}],"container-title":["Annals of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:15:40Z","timestamp":1757502940000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.informaworld.com\/openurl?genre=article&doi=10.1080\/10401230591002002&magic=crossref||D404A21C5BB053405B1A640AFFD44AE3"},"secondary":[{"URL":"http:\/\/triggered.stanford.clockss.org\/ServeContent?rft_id=info:doi\/10.1080\/10401230591002002","label":"CLOCKSS_SU"},{"URL":"http:\/\/triggered.edina.clockss.org\/ServeContent?rft_id=info:doi\/10.1080\/10401230591002002","label":"CLOCKSS_EDINA"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7,1]]}},"alternative-id":["N4260532H1W383U7"],"URL":"https:\/\/doi.org\/10.1080\/10401230591002002","relation":{},"ISSN":["1040-1237","1547-3325"],"issn-type":[{"value":"1040-1237","type":"print"},{"value":"1547-3325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}